Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Accord Healthcare Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (621)
Cancellation by sponsor (97)
Prescription medicine registration (44)
Australian public assessment report (AusPar) (2)

Date

2026 (1)
2025 (69)
2024 (32)
2023 (72)
2022 (85)
2021 (52)
2020 (52)
2019 (102)
2018 (64)
2017 (41)
2016 (70)
2015 (48)
2014 (37)
2013 (7)
2012 (16)
2011 (16)

Search

Sponsor content

764 result(s) found, displaying 521 to 530

EZETIMIBE INTAS ezetimibe 10mg tablet bottle pack (263221)

5 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZETIMIBE INTAS ezetimibe 10mg tablet bottle pack.
EZETIMIBE ASTRON ezetimibe 10mg tablet bottle pack (263227)

5 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZETIMIBE ASTRON ezetimibe 10mg tablet bottle pack.
EZINTAS ezetimibe 10mg tablet blister pack (263222)

5 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZINTAS ezetimibe 10mg tablet blister pack.
EZETIMIBE INTAS ezetimibe 10mg tablet blister pack (263220)

5 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZETIMIBE INTAS ezetimibe 10mg tablet blister pack.
EZINTAS ezetimibe 10mg tablet bottle pack (263223)

5 October 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EZINTAS ezetimibe 10mg tablet bottle pack.
Onsetron 4 mg/2 mL, Ondansetron injection, 4 mg/2 mL, Solution for injection, Glass Ampoules Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
MIDAZOLAM AN Midazolam (as hydrochloride) 5 mg/1 mL solution for injection ampoules Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
METHACCORD INJECTION methotrexate 1000mg/10mL injection vial Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
Onsetron 8 mg/4 mL, Ondansetron injection, 8 mg/4 mL, Solution for injection, Glass Ampoules Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
MIDAZOLAM AN Midazolam (as hydrochloride) 15 mg/3 mL solution for injection ampoules Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd

Pages

First page
Previous page
…
Page 49
Page 50
Page 51
Page 52
Current page 53
Page 54
Page 55
Page 56
Page 57
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.